GlassScriptPhysician profile
James H Barnett
NPI 1356484497
$43,200.91
in general payments reported to CMS, 2019-2025
41 companies · $2,258 in 2025
The $2,258 reported for 2025 was more than what 85% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,821 · 2020: $8,153 · 2021: $4,324 · 2022: $6,854 · 2023: $10K · 2024: $2,498 · 2025: $2,258.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,848 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,400 · Travel and Lodging: $2,792 · Education: $9.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,847.81 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,400.00 |
| Travel and Lodging | $2,792.20 |
| Education | $9.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $11,335.35 | 2019-2025 | Aveir, Optis, Jot Dx |
| Astrazeneca Pharmaceuticals LP | $8,970.20 | 2019-2025 | Farxiga, Lokelma, Wainua |
| Medtronic Vascular, INC. | $4,605.91 | 2019-2020 | |
| Penumbra, INC. | $3,067.09 | 2023 | Indigo System |
| Boston Scientific Corporation | $2,371.87 | 2019-2025 | Avvigo Guidance System, General - Balloon Catheters, Opticross |
| Amgen INC. | $1,741.89 | 2019-2025 | Repatha, Repatha |
| Novartis Pharmaceuticals Corporation | $1,560.70 | 2019-2024 | |
| Terumo Medical Corporation | $1,203.44 | 2019-2020 | |
| Amarin Pharma, INC. | $1,105.48 | 2019-2022 | |
| Pfizer INC. | $1,103.03 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $779.56 | 2019-2024 | Jardiance, Synjardy |
| Medtronic, INC. | $743.20 | 2021-2025 | Corevalve Evolut R, Hawkone |
| E.R. Squibb & Sons, L.L.C. | $590.46 | 2019-2025 | Camzyos, Eliquis |
| Merck Sharp & Dohme LLC | $427.23 | 2021-2025 | Verquvo, Belsomra |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $367.47 | 2020-2025 | Lifevest |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $354.01 | 2019-2023 | Impella |
| Actelion Pharmaceuticals US, INC. | $337.91 | 2024-2025 | Opsumit, Uptravi, Opsynvi |
| Novo Nordisk INC | $276.47 | 2022-2025 | Wegovy |
| Janssen Pharmaceuticals, INC | $274.44 | 2019-2024 | Xarelto |
| Cordis US Corp. | $225.60 | 2021-2023 | Zephyr |
| Ge Healthcare | $214.50 | 2022-2025 | |
| Axonics, INC. | $204.51 | 2022-2023 | Axonics |
| Cvrx, INC. | $166.50 | 2025 | Barostim Neo System |
| Shockwave Medical, INC | $163.34 | 2022 | |
| Tactile Systems Technology INC | $154.90 | 2021-2025 | Flexitouch Plus, Entre Plus, Nimbl |
| Sanofi-Aventis U.S. LLC | $149.54 | 2019-2020 | |
| Edwards Lifesciences Corporation | $94.09 | 2020 | |
| Lilly USA, LLC | $85.37 | 2019-2020 | |
| Lundbeck LLC | $75.84 | 2019-2021 | |
| Astellas Pharma US INC | $75.13 | 2019-2021 | |
| Kiniksa Pharmaceuticals International, Plc | $52.12 | 2024 | Arcalyst |
| Alnylam Pharmaceuticals INC. | $47.99 | 2025 | Amvuttra |
| Esperion Therapeutics, INC. | $44.81 | 2020-2021 | |
| Idorsia Pharmaceuticals US INC | $43.78 | 2022 | |
| Philips North America LLC | $41.46 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $36.72 | 2019-2020 | |
| Stryker Corporation | $29.52 | 2025 | Artix Mt |
| Kiniksa Pharmaceuticals, LTD. | $23.47 | 2023 | Arcalyst |
| Bayer Healthcare Pharmaceuticals INC. | $22.60 | 2022 | |
| Lexicon Pharmaceuticals, INC. | $17.52 | 2023 | Inpefa |
| Heartflow, INC. | $15.89 | 2023 | Ffrct |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Barnett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.